Association of a DNA damage response deficiency (DDRD) assay and prognosis in early-stage esophageal adenocarcinoma.

Richard Turkington(Queen's University Belfast), Richard D. Kennedy(Queen's University Belfast), Colin Purcell(University of Ulster), Ken Arthur(Queen's University Belfast), Ricky A. Sharma(Siemens Healthcare (United States)), Manuel Salto‐Tellez(Queen's University Belfast), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), Stephen McQuaid(Queen's University Belfast), Richard H. Wilson(Arizona State University), Rebecca C. Fitzgerald(Cancer Research UK), Jacqueline A. James(Queen's University Belfast), Laura A. Hill(Queen's University Belfast), Timothy S. Davison, Damian McManus(Belfast Health and Social Care Trust), Martin Eatock(Queen's University Belfast), Thomas P. MacGregor(University of Oxford), Patrick Johnston, Paul Harkin
Journal of Clinical Oncology
May 20, 2014
Cited by 3


Related Papers